![](/img/cover-not-exists.png)
1416PImmunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO)
Ferrara, R, Naigeon, M, Auclin, E, Duchemann, B, Cassard, L, Medhi, J, Boselli, L, Grivel, J, Desnoyer, A, Mezquita, L, Aboubakar, F, Hendriks, L, Planchard, D, Caramella, C, Remon, J, Ngocamus, M, NiVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy292.038
Date:
October, 2018
File:
PDF, 77 KB
english, 2018